Ipathlabs Medical Solutions Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-12-2024
- Paid Up Capital ₹ 4.94 M
as on 25-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 25-12-2024
- Revenue 189.66%
(FY 2022)
- Profit 166.78%
(FY 2022)
- Ebitda 223.07%
(FY 2022)
- Net Worth 1716.63%
(FY 2022)
- Total Assets 116.78%
(FY 2022)
About Ipathlabs Medical Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.94 M.
The company currently has active open charges totaling ₹4.50 M.
Koteswara Nidamanuri, Sumanth Kavuri, and Rampalli Vajjalu serve as directors at the Company.
- CIN/LLPIN
U85300TG2020PTC139324
- Company No.
139324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ipathlabs Medical Solutions?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koteswara Nidamanuri  | Director | 18-Feb-2020 | Current |
| Sumanth Kavuri | Additional Director | 20-Mar-2021 | Current |
| Rampalli Vajjalu | Director | 29-Jun-2020 | Current |
Financial Performance of Ipathlabs Medical Solutions.
Ipathlabs Medical Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 189.66% increase. The company also saw a substantial improvement in profitability, with a 166.78% increase in profit. The company's net worth Soared by an impressive increase of 1716.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ipathlabs Medical Solutions?
In 2022, Ipathlabs Medical Solutions had a promoter holding of 65.60% and a public holding of 34.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shreshtha Health Pro Private LimitedActive 10 months 29 daysKoteswara Nidamanuri is a mutual person
- Suhrut Multi Business Solutions Private LimitedActive 6 years 9 months
Rampalli Vajjalu is a mutual person
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2023 | Hdfc Bank Limited | ₹4.50 M | Open |
How Many Employees Work at Ipathlabs Medical Solutions?
Unlock and access historical data on people associated with Ipathlabs Medical Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ipathlabs Medical Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipathlabs Medical Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
